Promimic

Based in Sweden, Promimic is a startup founded in 2007. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

Promimic’s state-of-the-art nanotechnology, HAnano Surface®, makes it possible to create a unique bioactive surface on any implant. HAnano Surface has demonstrated faster and stronger osseointegration in over 30 in vivo and in vitro studies, with over 150,000 clinical applications to date.